These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6482445)

  • 1. Effects of intravenous versus intraatrial administration of doxorubicin on the function and structure of the heart.
    Edington H; Mayer D; Au FC; Elfenbein IB; Bove AA; Smalley RV
    J Surg Oncol; 1984 Sep; 27(1):12-7. PubMed ID: 6482445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin affects both the number and the morphology of specific atrial granules in dog heart.
    Bellini O; Danesi R; Bernardini N; Cardini G; Marzilli M; del Tacca M
    Anticancer Res; 1988; 8(4):599-604. PubMed ID: 3178151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of doxorubicin on [omega-I-131]heptadecanoic acid myocardial scintigraphy and echocardiography in dogs.
    Styles CB; Noujaim AA; Jugdutt BI; Sykes TR; Bain GO; Shnitka TK; Hooper HR
    J Nucl Med; 1983 Nov; 24(11):1012-8. PubMed ID: 6631522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in rats.
    Kertmen N; Aksoy S; Uner A; Sargon M; Ozkayar O; Keskin O; Babacan T; Sarici F; Sendur MA; Arik Z; Akin S; Altundag K
    Anticancer Res; 2015 Feb; 35(2):857-64. PubMed ID: 25667467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with ICRF-187 allows a marked increase in the total cumulative dose of doxorubicin tolerated by beagle dogs.
    Herman EH; Ferrans VJ; Young RS; Hamlin RL
    Drugs Exp Clin Res; 1988; 14(9):563-70. PubMed ID: 3147886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-ultramicrotomy as a tool for the assessment of doxorubicine cardiotoxicity in rats.
    Holderegger C; Zbinden G
    Exp Cell Biol; 1980; 48(5):349-55. PubMed ID: 7389974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Pathol; 1980 Apr; 99(1):13-42. PubMed ID: 7361854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs.
    Herman EH; Ferrans VJ; Young RS; Hamlin RL
    Cancer Res; 1988 Dec; 48(23):6918-25. PubMed ID: 3141049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower incidence of doxorubicin-induced cardiomyopathy by once-a-week low-dose administration.
    Anders RJ; Shanes JG; Zeller FP
    Am Heart J; 1986 Apr; 111(4):755-9. PubMed ID: 3513506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of melatonin on the cardiotoxicity of doxorubicin.
    Balli E; Mete UO; Tuli A; Tap O; Kaya M
    Histol Histopathol; 2004 Oct; 19(4):1101-8. PubMed ID: 15375752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts.
    Kang YJ; Sun X; Chen Y; Zhou Z
    Chem Res Toxicol; 2002 Jan; 15(1):1-6. PubMed ID: 11800590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-induced canine CHF: advantages and disadvantages.
    Astra LI; Hammond R; Tarakji K; Stephenson LW
    J Card Surg; 2003; 18(4):301-6. PubMed ID: 12869174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology.
    Sparano BM; Gordon G; Hall C; Iatropoulos MJ; Noble JF
    Cancer Treat Rep; 1982 May; 66(5):1145-58. PubMed ID: 7083217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse.
    Flandina C; Sanguedolce R; Rausa L; D'Alessandro N
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):259-72. PubMed ID: 2128759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.
    Jackson JA; Reeves JP; Muntz KH; Kruk D; Prough RA; Willerson JT; Buja LM
    Am J Pathol; 1984 Oct; 117(1):140-53. PubMed ID: 6486242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects.
    Jensen RA; Acton EM; Peters JH
    J Cardiovasc Pharmacol; 1984; 6(1):186-200. PubMed ID: 6199603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
    Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF
    Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal, hemodynamic, and electrocardiographic evaluations of healthy dogs receiving long-term administration of doxorubicin.
    Alves de Souza RC; Camacho AA
    Am J Vet Res; 2006 Aug; 67(8):1319-25. PubMed ID: 16881842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of calcium in the toxicity of the myocardium.
    Borgers M
    Histochem J; 1981 Sep; 13(5):839-48. PubMed ID: 7298378
    [No Abstract]   [Full Text] [Related]  

  • 20. Copper and selenium deficiencies do not enhance the cardiotoxicity in rats due to chronic doxorubicin treatment.
    Fischer JG; Tackett RL; Howerth EW; Johnson MA
    J Nutr; 1992 Nov; 122(11):2128-37. PubMed ID: 1432253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.